Market Cap 3.40M
Revenue (ttm) 160,000.00
Net Income (ttm) -6.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,206.25%
Debt to Equity Ratio 0.03
Volume 27,400
Avg Vol 217,046
Day's Range N/A - N/A
Shares Out 3.23M
Stochastic %K 78%
Beta 1.81
Analysts Strong Sell
Price Target $3.00

Latest News on VRAX

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 17, 2024, 7:30 AM EST - 4 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders


Virax Biolabs to Participate at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs to Participate at ESCMID Global 2024